# Monte Rosa Therapeutics, Inc. (GLUE) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$54M |
| 2024 | -$81M |
| 2023 | -$143M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$50M |
| 2025-09-30 | -$33M |
| 2025-06-30 | -$16M |
| 2025-03-31 | $44M |
| 2024-09-30 | -$27M |
| 2024-06-30 | -$33M |
| 2024-03-31 | -$35M |
| 2023-09-30 | -$37M |
| 2023-06-30 | -$37M |
| 2023-03-31 | -$34M |

Source: [CompaniesByCap](https://companiesbycap.com/company/GLUE/operating-income)